Gemcitabine with carboplatin for advanced biliary tract cancers: A phase II single institution study

HPB

Volumn 12, Issue 6, 2010, Pages 418-426

  Williams, Kerry J ^a   Picus, Joel ^a   Trinkhaus, Kim ^a   Fournier, Chloe C ^a   Suresh, Rama ^a   James, Joan S ^a   Tan, Benjamin R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biliary; Chemotherapy < cholangiocarcinoma; Chemotherapy < gallbladder; Sholangiocarcinoma < liver gallbladder

Indexed keywords

CARBOPLATIN; FLUOROPYRIMIDINE; GEMCITABINE; PLATINUM;

ADULT; ADVANCED CANCER; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANEMIA; ARTICLE; ASCITES; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; BILIARY TRACT CANCER; CHOLANGITIS; CLINICAL ARTICLE; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DEHYDRATION; DEPRESSION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; GALLBLADDER CANCER; HUMAN; HYPERTRANSAMINASEMIA; MALE; NAUSEA; NEUTROPENIA; OBSTRUCTIVE JAUNDICE; OVERALL SURVIVAL; PAIN; PANCREATITIS; PHASE 2 CLINICAL TRIAL; PROGRESSION FREE SURVIVAL; SEPSIS; SIDE EFFECT; SMALL INTESTINE CANCER; SUICIDAL IDEATION; SURVIVAL RATE; THROMBOCYTOPENIA; VOMITING;

EID: 77956913435     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2010.00197.x     Document Type: Article

References (47)

1. Ahlgren J. (1993) Neoplasms of the Hepatobiliary System. New York: McGraw-Hill.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71-96.
3. Picus J, Myerson R, Drebin J, Strasberg S. (1998) A Phase II trial of continuous infusion (CIVI) 5-FU with 3-D conformal radiation in the adjuvant treatment of pancreatic, ampullary and biliary cancers. Proc Am Soc Clin Oncol 17:266a.
4. Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, et al. (2002) Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 95:1685-1695.
5. Czito BG, Hurwitz HI, Clough RW, Tyler DS, Morse MA, Clary BM et al. (2005) Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experience. Int J Radiat Oncol Biol Phys 62:1030-1034.
6. Shani M, Hart J, Modan B. (1974) Cancer of the biliary system: a study of 445 cases. Br J Surg 61:98-100.
7. Hamrick RE Jr, Liner FJ, Hastings PR, Cohn I Jr. (1982) Primary carcinoma of the gallbladder. Ann Surg 195:270-273.
8. Yeo CJ, Pitt HA, Cameron JL. (1990) Cholangiocarcinoma. Surg Clin North Am 70:1429-1447.
9. Bengmark S, Ekberg H, Evander A, Klofver-Stahl B, Tranberg KG. (1988) Major liver resection for hilar cholangiocarcinoma. Ann Surg 207:120-125.
10. Nagorney DM, Donohue JH, Farnell MB, Schleck CD, Ilstrup DM. (1993) Outcomes after curative resections of cholangiocarcinoma. Arch Surg 128:871-877, discussion 77-79
11. Kraybill WG, Lee H, Picus J, Ramachandran G, Lopez MJ, Kucik N et al. (1994) Multidisciplinary treatment of biliary tract cancers. J Surg Oncol 55:239-245.
12. Glimelius B, Hoffman K, Sjoden PO, Jacobsson G, Sellstrom H, Enander LK et al. (1996) Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 7:593-600.
13. Davis HL Jr, Ramirez G, Ansfield FJ. (1974) Adenocarcinomas of stomach, pancreas, liver, and biliary tracts. Survival of 328 patients treated with fluoropyrimidine therapy. Cancer 33:193-197.
14. Ueno H, Okusaka T, Ikeda M, Takezako Y, Morizane C. (2004) Phase II study of S-1 in patients with advanced biliary tract cancer. Br J Cancer 91:1769-1774.
15. Falkson G, MacIntyre JM, Moertel CG. (1984) Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer. Cancer 54:965-969.
16. Choi CW, Choi IK, Seo JH, Kim BS, Kim JS, Kim CD et al. (2000) Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas. Am J Clin Oncol 23:425-428.
17. Gebbia V, Giuliani F, Maiello E, Colucci G, Verderame F, Borsellino N et al. (2001) Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study. J Clin Oncol 19:4089-4091.
18. Kubicka S, Rudolph KL, Tietze MK, Lorenz M, Manns M. (2001) Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas. Hepatogastroenterology 48:783-789.
19. Raderer M, Hejna MH, Valencak JB, Kornek GV, Weinlander GS, Bareck E et al. (1999) Two consecutive phase II studies of 5-fluorouracil/ leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer. Oncology 56:177-180.
20. Penz M, Kornek GV, Raderer M, Ulrich-Pur H, Fiebiger W, Lenauer A et al. (2001) Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. Ann Oncol 12:183-186.
21. Tsavaris N, Kosmas C, Gouveris P, Gennatas K, Polyzos A, Mouratidou D et al. (2004) Weekly gemcitabine for the treatment of biliary tract and gallbladder cancer. Invest New Drugs 22:193-198.
22. von Delius S, Lersch C, Schulte-Frohlinde E, Mayr M, Schmid RM, Eckel F. (2005) Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma. BMC Cancer 5:61.
23. Park JS, Oh SY, Kim SH, Kwon HC, Kim JS, Jin-Kim H et al. (2005) Single-agent gemcitabine in the treatment of advanced biliary tract cancers: a phase II study. Jpn J Clin Oncol 35:68-73.
24. Okusaka T, Ishii H, Funakoshi A, Yamao K, Ohkawa S, Saito S et al. (2006) Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer. Cancer Chemother Pharmacol 57:647-653.
25. Gerardo Arroyo JG, Rubio B, Orlandi L, Yanez M, Gamargo C, Ahumada M et al. Sociedad de Oncologia del NOA; GETICS, Salta, Argentina; Oncologia Clinica Alemana, Santiago, Chile; Universidad de Chile, Santiago, Chile; Sociedad de Oncologia del NOA; GETICS, Tucuman, Argentina; Sociedad de Oncologia del NOA, Jujuy, Argentina; GETICS, Viedma, Argentina. (2001) Gemcitabine in advanced biliary tract cancer. Experience from Chile and Argentina in Phase II trials. Proc Am Soc Clin Oncol 20:157a.
26. Kim HJ, Lee NS, Lee SC, Bae SB, Kim CK, Cheon YG et al. (2009) A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer. Cancer Chemother Pharmacol 64:371-377.
27. Alberts SR, Al-Khatib H, Mahoney MR, Burgart L, Cera PJ, Flynn PJ et al. (2005) Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial. Cancer 103:111-118.
28. Riechelmann RP, Townsley CA, Chin SN, Pond GR, Knox JJ. (2007) Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer. Cancer 110:1307-1312.
29. Koeberle D, Saletti P, Borner M, Gerber D, Dietrich D, Caspar CB et al. (2008) Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research. J Clin Oncol 26:3702-3708.
30. Thongprasert S. (2005) The role of chemotherapy in cholangiocarcinoma. Ann Oncol 16 (Suppl. 2):ii93-ii96.
31. Meyerhardt JA, Zhu AX, Stuart K, Ryan DP, Blaszkowsky L, Lehman N et al. (2008) Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer. Dig Dis Sci 53:564-570.
32. Andre T, Tournigand C, Rosmorduc O, Provent S, Maindrault-Goebel F, Avenin D et al. (2004) Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study. Ann Oncol 15:1339-1343.
33. Kim ST, Park JO, Lee J, Lee KT, Lee JK, Choi SH et al. (2006) A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. Cancer 106:1339-1346.
34. Harder J, Riecken B, Kummer O, Lohrmann C, Otto F, Usadel H et al. (2006) Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer. Br J Cancer 95:848-852.
35. Eckel F, Schmid RM. (2007) Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials. Br J Cancer 96:896-902.
36. Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A et al. (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362:1273-1281.
37. Ardizzoni A, Boni L, Tiseo M, Fossella FV, Schiller JH, Paesmans M et al. (2007) Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis. J Natl Cancer Inst 99:847-857.
38. Dogliotti L, Carteni G, Siena S, Bertetto O, Martoni A, Bono A et al. (2007) Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: results of a randomized phase 2 trial. Eur Urol 52:134-141.
39. Pfisterer J, Plante M, Vergote I, du Bois A, Hirte H, Lacave AJ et al. (2006) Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG. J Clin Oncol 24:4699-4707.
40. Yardley DA, Burris HA, 3rd, Simons L, Spigel DR, Greco FA, Barton JH et al. (2008) A phase II trial of gemcitabine/carboplatin with or without trastuzumab in the first-line treatment of patients with metastatic breast cancer. Clin Breast Cancer 8:425-431.
41. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R et al. (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228-247.
42. Simon R. (1989) Optimal two-stage designs for Phase II trials. Controll Clin Trials 10:1-10.
43. Taal BG, Audisio RA, Bleiberg H, Blijham GH, Neijt JP, Veenhof CH et al. (1993) Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group Study. Ann Oncol 4:607-609.
44. Kajanti M, Pyrhonen S. (1994) Epirubicin-sequential methotrexate-5- fluorouracil-leucovorin treatment in advanced cancer of the extrahepatic biliary system. A phase II study. Am J Clin Oncol 17:223-226.
45. Ekstrom K, Hoffman K, Linne T, Eriksson B, Glimelius B. (1998) Singledose etoposide in advanced pancreatic and biliary cancer, a phase II study. Oncol Rep 5:931-934.
46. Papakostas P, Kouroussis C, Androulakis N, Samelis G, Aravantinos G, Kalbakis K et al. (2001) First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study. Eur J Cancer 37:1833-1838.
47. Harvey JH, Smith FP, Schein PS. (1984) 5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract. J Clin Oncol 2: 1245-1248